{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:05:25Z","timestamp":1790694325107,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009629","name":"Fondazione Cassa Di Risparmio Di Trento E Rovereto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004004","name":"Universit\u00e0 degli Studi di Trento","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004004","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus-disease 2019 (COVID-19) outbreak precipitated prolonged lock-down measures. The subsequent social distancing, isolation, and reduction in mobility increased psychological stress, which may worsen Parkinson\u2019s disease (PD). Therefore, telemedicine has been proposed to provide care to PD patients. To evaluate the effects of lock-down on motor and nonmotor symptoms in PD patients during the COVID-19 pandemic and the feasibility of telemedicine. Motor and nonmotor aspects were longitudinally assessed using structured questionnaires at baseline (in-person, February 2020) and at follow-up (remote web-based video, lock-down) evaluation. Of the seventeen PD patients evaluated at baseline, fourteen agreed to participate in, and completed follow-up evaluations. There was an impairment of nonmotor aspects measured with the MDS-UPDRS part I (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) during lock-down. Nine patients participated independently in the telemedicine evaluation while five needed help from relatives. Our preliminary findings suggest an impairment of nonmotor symptoms in PD patients and support the feasibility and need for telemedicine in monitoring PD patients during the COVID-19 pandemic, to guarantee optimal assistance with reducing the burden of infection. Our findings also suggest that movement disorder clinics should be carefully considering socio-demographics and clinical features when developing telemedicine programs.<\/jats:p>","DOI":"10.1007\/s13760-021-01732-z","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:03:51Z","timestamp":1625166231000},"page":"1191-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Lockdown effects on Parkinson\u2019s disease during COVID-19 pandemic: a pilot study"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-3020","authenticated-orcid":false,"given":"Marika","family":"Falla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Dodich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Papagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Narduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Pierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Turella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"1732_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna) 124:901\u2013905","journal-title":"J Neural Transm (Vienna)"},{"issue":"369","key":"1732_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1379","volume":"6","author":"A Venkatesh","year":"2020","unstructured":"Venkatesh A, Edirappuli S (2020) Social distancing in covid-19: what are the mental health implications? BMJ 6(369):m1379. https:\/\/doi.org\/10.1136\/bmj.m1379","journal-title":"BMJ"},{"key":"1732_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JPD-202038","volume":"10","author":"RC Helmich","year":"2020","unstructured":"Helmich RC, Bloem BR (2020) The impact of the COVID-19 pandemic on Parkinson\u2019s disease: hidden sorrows and emerging opportunities. J Parkinson Dis 10:351\u2013354","journal-title":"J Parkinson Dis"},{"key":"1732_CR4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1056\/NEJMp2003539","volume":"382","author":"JE Hollander","year":"2020","unstructured":"Hollander JE, Carr BG (2020) Virtually perfect? Telemedicine for COVID-19. N Engl J Med 382:1679\u20131681","journal-title":"N Engl J Med"},{"key":"1732_CR5","unstructured":"International Parkinson and Movement Disorder Society. https:\/\/www.movementdisorders.org\/MDS\/About\/Committees--Other-Groups\/Telemedicine-in-Your-Movement-Disorders-Practice-A-Step-by-Step-Guide.htm. Accessed 9 April 2021"},{"key":"1732_CR6","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/mds.23145","volume":"25","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S et al (2010) Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson\u2019s disease. Mov Disord 25:1652\u20131659","journal-title":"Mov Disord"},{"key":"1732_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/mds.22498","volume":"24","author":"KM Biglan","year":"2009","unstructured":"Biglan KM, Voss TS, Deuel LM, Miller D, Eason S, Fagnano M et al (2009) Telemedicine for the care of nursing home residents with Parkinson\u2019s disease. Mov Disord 24:1073\u20131076","journal-title":"Mov Disord"},{"key":"1732_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.parkreldis.2012.10.008","volume":"19","author":"A Abdolahi","year":"2013","unstructured":"Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM (2013) Potential reliability and validity of a modified version of the unified Parkinson\u2019s disease rating scale that could be administered remotely. Parkinsonism Relat Disord 19:218\u2013221","journal-title":"Parkinsonism Relat Disord"},{"key":"1732_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"1732_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"1732_CR11","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25:2649\u20132653","journal-title":"Mov Disord"},{"key":"1732_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"1732_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385\u2013396","journal-title":"J Health Soc Behav"},{"key":"1732_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement disorder society UPDRS revision task force. Movement disorder society-sponsored revision of the unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170","journal-title":"Mov Disord"},{"key":"1732_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2016.06.008","volume":"367","author":"G Santangelo","year":"2016","unstructured":"Santangelo G, Falco F, D\u2019Iorio A, Cuoco S, Raimo S, Amboni M et al (2016) Anxiety in early Parkinson\u2019s disease: validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS). J Neurol Sci 367:158\u2013161","journal-title":"J Neurol Sci"},{"key":"1732_CR16","doi-asserted-by":"crossref","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum D, Huang V, Adey M et al (1982-1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37\u201349","DOI":"10.1016\/0022-3956(82)90033-4"},{"key":"1732_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the apathy evaluation scale. Psychiatry Res 38:143\u2013162","journal-title":"Psychiatry Res"},{"key":"1732_CR18","first-page":"42","volume":"11","author":"J Lubben","year":"1998","unstructured":"Lubben J (1998) Assessing social networks among elderly populations. Fam Commun Health J Health Promot Maintenance 11:42\u201352","journal-title":"Fam Commun Health J Health Promot Maintenance"},{"key":"1732_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score. Age Ageing 26:353\u2013357","journal-title":"Age Ageing"},{"key":"1732_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res 4:241\u2013248","journal-title":"Qual Life Res"},{"key":"1732_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ageing\/afi196","volume":"34","author":"L Yardley","year":"2005","unstructured":"Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C (2005) Development and initial validation of the falls efficacy scale-international (FES-I). Age Ageing 34:614\u2013619","journal-title":"Age Ageing"},{"key":"1732_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/gerona\/50A.1.M28","volume":"50","author":"LE Powell","year":"1995","unstructured":"Powell LE, Myers AM (1995) The activities-specific balance confidence (ABC) scale. J Gerontol Med Sci 50:28\u201334","journal-title":"J Gerontol Med Sci"},{"key":"1732_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.gaitpost.2009.07.108","volume":"30","author":"A Nieuwboer","year":"2009","unstructured":"Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T et al (2009) Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson\u2019s disease and their careers. Gait Posture 30:459\u2013463","journal-title":"Gait Posture"},{"key":"1732_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123","journal-title":"Arch Neurol"},{"key":"1732_CR25","unstructured":"Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html. Accessed 9 April 2021"},{"key":"1732_CR26","first-page":"1521","volume":"138","author":"L Jianjun","year":"2007","unstructured":"Jianjun L (2007) A two-step rejection procedure for testing multiple hypotheses. J Stat Plan Infer 138:1521\u20131527","journal-title":"J Stat Plan Infer"},{"issue":"10","key":"1732_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/mds.28254","volume":"35","author":"G Palermo","year":"2020","unstructured":"Palermo G, Tommasini L, Baldacci F, Del Prete E, Siciliano G, Ceravolo R (2020) Impact of coronavirus disease 2019 pandemic on cognition in Parkinson\u2019s disease. Mov Disord 35(10):1717\u20131718. https:\/\/doi.org\/10.1002\/mds.28254","journal-title":"Mov Disord"},{"key":"1732_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/ene.12740","volume":"22","author":"CH Lin","year":"2015","unstructured":"Lin CH, Lin JW, Liu YC, Chang CH, Wu RM (2015) Risk of Parkinson\u2019s disease following anxiety disorders: a nationwide population-based cohort study. Eur J Neurol 22:1280\u20131287","journal-title":"Eur J Neurol"},{"key":"1732_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464\u2013474","journal-title":"Lancet Neurol"},{"key":"1732_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1176\/jnp.7.1.23","volume":"7","author":"RS Marin","year":"1995","unstructured":"Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B (1995) Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 7:23\u201330","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1732_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/13607860802343225","volume":"12","author":"A McKinlay","year":"2008","unstructured":"McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D (2008) Neuropsychiatric problems in Parkinson\u2019s disease: comparisons between self and caregiver report. Aging Ment Health 12:647\u2013653","journal-title":"Aging Ment Health"},{"key":"1732_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/gps.4697","volume":"33","author":"R Radakovic","year":"2018","unstructured":"Radakovic R, Davenport R, Starr JM, Abrahams S (2018) Apathy dimensions in Parkinson\u2019s disease. Int J Geriatr Psychiatry 33:151\u2013158","journal-title":"Int J Geriatr Psychiatry"},{"key":"1732_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1355617712001385","volume":"19","author":"DM Schiehser","year":"2013","unstructured":"Schiehser DM, Liu L, Lessig SL, Song DD, Obtera KM, Burke Iii MM et al (2013) Predictors of discrepancies in Parkinson\u2019s disease patient and caregiver ratings of apathy, disinhibition, and executive dysfunction before and after diagnosis. J Int Neuropsychol Soc 19:295\u2013304","journal-title":"J Int Neuropsychol Soc"},{"key":"1732_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.11138\/FNeur\/2018.33.1.031","volume":"33","author":"V Valentino","year":"2018","unstructured":"Valentino V, Iavarone A, Amboni M, Moschiano F, Picillo M, Petretta V et al (2018) Apathy in Parkinson\u2019s disease: differences between caregiver\u2019s report and self-evaluation. Funct Neurol 33:31\u201335","journal-title":"Funct Neurol"},{"key":"1732_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord 23:183\u2013189","journal-title":"Mov Disord"},{"key":"1732_CR36","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/mds.28176","volume":"35","author":"A Fasano","year":"2020","unstructured":"Fasano A, Cereda E, Barichella M, Cassani E, Ferri V, Zecchinelli AL, Pezzoli G (2020) COVID-19 in Parkinson\u2019s disease patients living in Lombardy, Italy. Mov Disord 35:1089\u20131093","journal-title":"Mov Disord"},{"key":"1732_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mds.28104","volume":"35","author":"A Antonini","year":"2020","unstructured":"Antonini A, Leta V, Teo J, Chaudhuri KR (2020) Outcome of Parkinson\u2019s disease patients affected by COVID-19. Mov Disord 35:905\u2013908. https:\/\/doi.org\/10.1002\/mds.28104","journal-title":"Mov Disord"},{"key":"1732_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.parkreldis.2020.08.012","volume":"78","author":"A Fasano","year":"2020","unstructured":"Fasano A, Elia AE, Dallocchio C, Canesi M, Alimonti D, Sorbera C, Alonso-Canovas A, Pezzoli G (2020) Predictors of COVID-19 outcome in Parkinson\u2019s disease. Parkinsonism Relat Disord 78:134\u2013137. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.08.012","journal-title":"Parkinsonism Relat Disord"},{"key":"1732_CR39","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/mds.28325","volume":"35","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Schultz JL, Aldridge GM, Simmering JE, Narayanan NS (2020) Coronavirus disease 2019 case fatality and Parkinson\u2019s disease. Mov Disord 35:1914\u20131915. https:\/\/doi.org\/10.1002\/mds.28325","journal-title":"Mov Disord"},{"issue":"5","key":"1732_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/mds.28067","volume":"35","author":"SM Papa","year":"2020","unstructured":"Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang HL, Alcalay RN, Trenkwalder C, MDS-Scientific Issues Committee (2020) Impact of the COVID-19 pandemic on Parkinson\u2019s disease and movement disorders. Mov Disord 35(5):711\u2013715. https:\/\/doi.org\/10.1002\/mds.28067","journal-title":"Mov Disord"},{"issue":"2","key":"1732_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3233\/JPD-202463","volume":"11","author":"CA Artusi","year":"2021","unstructured":"Artusi CA, Romagnolo A, Ledda C, Zibetti M, Rizzone MG, Montanaro E, Bozzali M, Lopiano L (2021) COVID-19 and Parkinson\u2019s disease: what do we know so far? J Parkinsons Dis 11(2):445\u2013454. https:\/\/doi.org\/10.3233\/JPD-202463","journal-title":"J Parkinsons Dis"},{"key":"1732_CR42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/mds.28170","volume":"35","author":"R Cilia","year":"2020","unstructured":"Cilia R, Bonvegna S, Straccia G, Andreasi NG, Elia AE, Romito LM, Devigili G, Cereda E, Eleopra R (2020) Effects of COVID-19 on Parkinson\u2019s disease clinical features: a community-based case-control study. Mov Disord 35:1287\u20131292. https:\/\/doi.org\/10.1002\/mds.28170","journal-title":"Mov Disord"},{"key":"1732_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.567413","volume":"11","author":"F Motolese","year":"2020","unstructured":"Motolese F, Magliozzi A, Puttini F, Rossi M, Capone F, Karlinski K, Stark-Inbar A, Yekutieli Z, Di Lazzaro V, Marano M (2020) Parkinson\u2019s disease remote patient monitoring during the COVID-19 lockdown. Front Neurol 11:567413. https:\/\/doi.org\/10.3389\/fneur.2020.567413","journal-title":"Front Neurol"},{"issue":"4","key":"1732_CR44","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3233\/JPD-202121","volume":"10","author":"RB Schneider","year":"2020","unstructured":"Schneider RB, Myers TL, Tarolli CG, Amodeo K, Adams JL, Jensen-Roberts S et al (2020) Remote administration of the MDS-UPDRS in the time of COVID-19 and beyond. J Parkinsons Dis 10(4):1379\u20131382. https:\/\/doi.org\/10.3233\/JPD-202121","journal-title":"J Parkinsons Dis"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01732-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-021-01732-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01732-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T12:46:24Z","timestamp":1631709984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-021-01732-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s13760-021-01732-z","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}